Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.

Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.

Item
http://www.wikidata.org/entity/Q50560164
Physiologic and pathologic drug resistance in ovarian carcinoma--a hypothesis based on a clonal progression model.Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer.Encapsulation in nanoparticles improves anti-cancer efficacy of carboplatin.Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients.Treatment strategy for recurrent and refractory epithelial ovarian cancer: efficacy of high-dose chemotherapy with hematopoietic stem cell transplantationFirst-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidenceImmunohistochemical expression of platelet-derived growth factor receptors in ovarian cancer patients with long-term follow-up.Enhanced Antiproliferative Effect of Carboplatin in Cervical Cancer Cells Utilizing Folate-Grafted Polymeric Nanoparticles.Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival.A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer.Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer: a meta-analysisDrug exposure: still an excellent biomarker.High dose chemotherapy with autologous stem cell support in the treatment of patients with ovarian carcinoma: long term results for 105 patients.A multicenter randomized Phase II trial of granulocyte-colony stimulating factor-supported, platinum-based chemotherapy with flexible midcycle cisplatin administration in patients with advanced ovarian carcinoma. PSAMOMA Cooperative Group, Spain.
P2860

Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.

Item
http://www.wikidata.org/entity/Q50560164
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.
@en
Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.
@nl
type
label
Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.
@en
Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.
@nl
prefLabel
Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.
@en
Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921